Ex Vivo Drug Response Platform From KYAN Shows Clinical Utility in Non-Hodgkin Lymphoma Patients
SINGAPORE, July 28, 2025 / EINPresswire.com / -- A prospective clinical study published in JCO Precision Oncology, a journal of the American Society of Clinical Oncology (ASCO), confirms that KYAN Technologies' Optim.AI™ platform (Quadratic Phenotypic Optimization Platform, or QPOP) accurately predicts clinical response in relapsed/refractory non-Hodgkin lymphoma (R/R-NHL), including hard-to-treat subtypes where genomic testing often offers limited guidance.
This prospective clinical validation study, conducted in 117 patients across two tertiary cancer centers, represents the largest published cohort to date using an ex vivo functional precision medicine platform in lymphoma. The results demonstrated meaningful clinical utility, reporting both objective response rates (ORR) and Kaplan-Meier survival outcomes, with significantly longer progression-free survival (PFS) in patients treated with combinations prioritized by the platform. The study showed that functionally guided therapies delivered not just predictive concordance, but measurable clinical benefit in a real-world setting.
Key study findings:
• 74.5 percent test accuracy in predicting clinical response
• 59 percent ORR in patients treated with platform-guided combinations
• Three-fold improvement in PFS compared to prior treatment line
• Two-year survival analysis showed a statistically significant benefit over salvage therapy (P = 0.0191)
'This study reinforces the scientific rigor behind the platform by showing we can deliver reproducible, clinically concordant results across a large cohort of real patient samples,' said Edward K. Chow, PhD, KYAN Technologies' Chief Scientific Officer. 'We're especially grateful to the essential contributions of our clinical collaborators at the National University of Singapore (NUS), National University Hospital (NUH), and Singapore General Hospital (SGH). Their guidance, insights and commitment helped shape a platform that delivers timely, reliable, and actionable guidance for both physicians and patients.'
Optim.AI™ directly measures how live tumor cells respond to therapy. Using a proprietary experimental design, the platform tests hundreds of clinically relevant drug treatments at once, including standard-of-care regimens, off-label therapies with known safety profiles, and novel options, and ranks them based on predicted treatment response. This functional, patient-specific readout provides oncologists with real-time guidance tailored to the biology of each tumor.
'This study marks a defining milestone in Optim.AI™'s journey toward clinical adoption. With our clinical and analytical validation now published in a peer-reviewed journal, we're positioned to scale the platform in the U.S., starting with CLIA deployment and expanding through partnerships with leading clinicians and institutions,' said Hugo Saavedra, Chief Executive Officer of KYAN Technologies.
The results underscore the broader potential of functional precision medicine to inform treatment decisions and combination design across oncology. By capturing how each patient's tumor responds to a breadth of drug regimens, Optim.AI™ not only guides clinical care but also offers insights that can support off-label strategy, clinical trial selection, and future drug development.
About KYAN Technologies
KYAN Technologies is a functional precision oncology company accelerating the discovery and deployment of effective cancer treatments. Its proprietary platform, Optim.AI™, uses ex vivo testing and combinatorial analytics to generate phenotypic response data from patient-derived tumor samples. This approach provides a clinically actionable layer of insight that complements genomic and transcriptomic tools.
Optim.AI™ supports both patient care and drug development, helping clinicians identify tailored treatment options and enabling biopharma partners to prioritize combination strategies, select indications, and design smarter trials. Headquartered in Singapore, KYAN is expanding its U.S. presence to advance clinical deployment and strategic collaborations across oncology research and care.
For media inquiries contact:
Sudha Sruthi, Corporate Development
email us here
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
Is ZIM a Good Shipping Dividend Stock to Buy Now?
ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) is included among the 10 Best Shipping Stocks with Dividends. A fleet of vessels docking at a busy harbor, signaling the company's presence in global marine shipping. ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) ranks among the major players in the cargo shipping industry, operating a fleet of over 130 vessels, including large container ships that move goods for manufacturing and retail clients. Although the shipping sector tends to follow a boom-and-bust cycle, ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) benefits from having a comparatively modern fleet, which helps reduce fuel consumption and maintenance expenses. In addition, the company holds a strong presence on key global trade routes, particularly those connecting Asia and Europe. In the first quarter of 2025, ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) reported a strong cash position. The company's operating cash flow for the quarter came in at $855 million, up from $326 million in the same period last year. Its free cash flow also grew from $787 million to $303 million from the prior-year period. During the quarter, it returned $89 million to shareholders through dividends. The company currently pays a quarterly dividend of $0.74 per share. While we acknowledge the potential of ZIM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
Yahoo
14 minutes ago
- Yahoo
Keen to share your home with a Siamese cat? Find out everything there is to know about this breed
When you buy through links on our articles, Future and its syndication partners may earn a commission. Siamese cat overview Other names: Meezers Life expectancy: 12–15 years Size: 4–13lbs in weight, 11 inches in height Coat: pointed or colorpoint Eye colour: bright blue eyes Temperament: sociable, affectionate, vocal and intelligent Origin/native country: Thailand Siamese cats aren't hard to come by. Perhaps the most iconic example of this breed is the aptly named Si and Am in Disney's Lady and the Tramp, who are the sinister villains of the show. But in reality, this couldn't be further from the truth. Known for being affectionate, friendly, and sociable, Siamese cats are also loved by the masses for their distinctive narrow-faced look, fur coloring and beautiful blue eyes. This lap cat also has the pretty incredible ability to crave attention no matter the time of the day. Another thing to keep in mind about the Siamese is that they are rather vocal, so they could be ideal for someone who lives alone, or those who much prefer noise and chatter in their home compared to peace and quiet. And its reasons like this (and more) that have earned a 'meezer' the title of being one of the most popular cat breeds. We've compiled a guide on everything there is to know about this Velcro kitty and roped in the expertise of vet Dr Rebecca MacMillan. Are Siamese cats hypoallergenic? All allergy sufferers will be pleased to know that Siamese cats are classified as one of the hypoallergenic cat breeds due to their fur, which sheds a lot less than other breeds and the fact that they produce less of the Fel D1 protein, which can cause allergies in humans to flare up. 'These cats still produce the Fel D 1 protein in their saliva, which gets dispersed through their coat as they groom,' flags Dr MacMillan. Therefore, Siamese cats may still trigger some. But they might be less triggering than other breeds for some allergy sufferers. Are Siamese cats friendly? Despite how they are portrayed in the Disney film, Siamese cats are very friendly cats. They are also very affectionate, too. So if you love lots of love and cuddles from your fur friend, this curious cat, craves companionship and will be more than happy to snuggle up on your lap in the evening as long as they have had enough stimulation during the morning. 'I do have a bit of a soft spot for Siamese cats,' says Dr MacMillan. 'They are friendly, sociable, and enjoy spending time with people. However, they are also known for being vocal and demanding!' So much so, life with a Siamese cat will be anything but quiet as this breed is known for being one of the loudest cat breeds. 'They make great pets if you have time to give them lots of fuss and attention,' Dr MacMillan adds. Wisdom Panel Cat DNA Test | Amazon Not sure exactly what breed your cat is? This kit screens for 70+ breeds, 45 genetic health insights and 25+ physical traits – because knowing every detail about your cat helps you understand how best to care for them. View Deal Siamese cat health issues Siamese are generally healthy and often live to 15 years of age or more. But like many pedigree cats, Siamese are prone to certain health complaints. 'Siamese cats can suffer from asthma, and I have diagnosed a few over the years,' Dr MacMillan says. 'Inflammation of the airways causes breathing issues and wheezing in affected cats.' Amyloidosis is an inherited condition that affects Siamese. 'It causes abnormal proteins to be deposited in various organs around the body,' the veterinarian explains. 'This can cause problems with their ability to function properly. Kidney failure is very common in cats with amyloidosis.' Cancer is often found in this breed. 'No one quite knows for sure why they are more likely to develop it than other cats,' explains Dr MacMillan. 'Lymphoma is a common example and it can affect many areas of the body including the lymph nodes, digestive tract, chest, and kidneys. If detected early enough, it may be treatable with surgery or chemotherapy.' Nystagmus is another condition often seen in Siamese cats. Explaining the health condition, Dr MacMillan says: 'This causes their eyes to flicker slightly from side to side. It doesn't seem to cause them any problems however and their brain is still able to process the visual information okay.' How much exercise do Siamese cats need? As is the case with all cats, Siamese cats will require at least 30 minutes of exercise a day, which can be broken up into small bursts. Of course, pet exercise will look a lot different to human exercise. So while you wouldn't expect your cat to be lifting weights, a Siamese will be more than happy to chase some of the best toys for indoor cats around or play with the best automated cat toys to keep their mind and body engaged. But that said, this clever breed is an active and companionable four-legged feline. So the more engagement and mental stimulation it can get from you, the better. What grooming do Siamese cats need? Siamese cats tend to have short coats so they have minimal grooming needs. However, you will still need to brush them with one of the best cat brushes to keep their coat looking and feeling healthy. This will help to keep their coat glossy and can help get rid of dead fur during shedding seasons, rather than seeing it pile up around your home. It's also important to stay on top of regular nail trims and ear cleaning. How much do Siamese cats cost? Generally speaking, Siamese cats can set you back anywhere between $250 to $2,500. But this will all depend on pedigree, breeder and the area you purchase your Siamese cat from and the rarity of colorations. The higher end of the scale can make a Siamese cat quite expensive. However, if you are lucky enough to adopt a Siamese cat you can expect to pay up to $300. Should I get a Siamese? A Siamese cat is often known as a Velcro cat, as this breed would much rather be in the company of others than its own. This means a Siamese cat will expect a lot of attention and it will make this demand known with its vocal chirping and chatter. Therefore, a Siamese cat might be best for extroverts or loud homes or perhaps someone who lives alone who might favor some companionship in the form of a fur friend. The Complete Guide To Siamese Cats | Amazon Author and experienced Siamese owner Candace Darnforth used interviews with 11 top Siamese breeders to create the perfect guidebook for any new Siamese Deal Read next: Facts about Siamese cats Solve the daily Crossword
Yahoo
an hour ago
- Yahoo
Old Trump speech falsely linked to South Korea trade deal
Social media posts have recirculated an old video of US President Donald Trump and falsely presented it as depicting him calling South Korean leader Lee Jae Myung a "bad negotiator" after their countries agreed a trade deal. The clip in fact shows Trump criticising then president Barack Obama as he launched his presidential campaign in June 2015. "Trump mocks Lee Jae Myung as a bad negotiator," reads a Korean-language post featuring the clip on Naver Band, a South Korean forum, on July 31, 2025. "[Trump] mocked Lee as soon as the tariff negotiations finished. [Lee] has become a total pushover," it continues. The video shows Trump saying, "The people negotiating don't have a clue. Our president doesn't have a clue. He's a bad negotiator." But its Korean subtitles mistranslate "our president" as "their president". The clip was also shared in similar posts on multiple right-wing South Korean circles on Facebook, as well as on YouTube. "The way that fool Lee acted as he did, no wonder he is being mocked," read a comment on one of the posts. Another said: "An international embarrassment to be used like that, then mocked by the US president." Under the trade deal, the United States will impose a 15 percent tariff on South Korean imports -- down from the previously threatened 25 percent -- in exchange for $350 billion in South Korean investments in US industries and $100 billion in energy purchases (archived link). A keyword search on Google found the clip corresponds to a part of a speech Trump gave on June 16, 2015, when he announced his bid for the presidency (archived link). At around the 18:50 mark of the speech posted in full by CSPAN, Trump makes the comment: "The people negotiating don't have a clue. Our president doesn't have a clue. He's a bad negotiator." This was part of a broader tirade against the Obama administration's trade and foreign policies. Trump then references a prisoner swap involving US soldier Bowe Bergdahl to illustrate his criticism of Obama's negotiating skills. Bergdahl was a US Army sergeant who was captured by the Taliban in 2009 after walking off his post in Afghanistan and was released in 2014 in exchange for five Taliban detainees held at Guantanamo Bay (archived link). "We get Bergdahl. We get a traitor. We get a no-good traitor, and they get the five people that they wanted for years, and those people are now back on the battlefield trying to kill us. That's the negotiator we have," Trump said. A full transcript of the speech published by Time magazine also shows Trump was referring to Obama (archived link). Nowhere in the video or transcript does Trump mention South Korea or Lee Jae Myung. AFP has previously debunked similar instances of Trump remarks and social media posts being misrepresented as references to South Korea.
